002793.SZ
Luoxin Pharmaceuticals Group Stock Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 4.66
−6.80%Margins
Gross margin
53.1%
EBITDA margin
-3.9%
EBIT margin
-11.5%
Net margin
-11.4%
FCF margin
8.7%
-24.6%
Return on equity
-7.6%
Return on assets
-12.8%
Return on invested capital
0.65x
Asset turnover
CNY 238.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026